Scopus BioPharma (SCPS) Competitors $0.0003 0.00 (0.00%) As of 05/14/2025 02:07 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock SCPS vs. VAXX, EVLO, GNCAQ, GNCA, ARDS, STAB, SMFL, AMPE, CMRA, and EFTRShould you be buying Scopus BioPharma stock or one of its competitors? The main competitors of Scopus BioPharma include Vaxxinity (VAXX), Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Smart for Life (SMFL), Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry. Scopus BioPharma vs. Vaxxinity Evelo Biosciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Statera Biopharma Smart for Life Ampio Pharmaceuticals Comera Life Sciences eFFECTOR Therapeutics Scopus BioPharma (NASDAQ:SCPS) and Vaxxinity (NASDAQ:VAXX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends. Which has stronger earnings and valuation, SCPS or VAXX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScopus BioPharmaN/AN/A-$11.61MN/AN/AVaxxinityN/AN/A-$56.93M-$0.45-0.02 Do insiders and institutionals have more ownership in SCPS or VAXX? 82.9% of Vaxxinity shares are held by institutional investors. 5.1% of Scopus BioPharma shares are held by insiders. Comparatively, 64.1% of Vaxxinity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, SCPS or VAXX? Scopus BioPharma has a beta of -0.29, indicating that its stock price is 129% less volatile than the S&P 500. Comparatively, Vaxxinity has a beta of -22.53, indicating that its stock price is 2,353% less volatile than the S&P 500. Does the media refer more to SCPS or VAXX? In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Vaxxinity'saverage media sentiment score. Company Overall Sentiment Scopus BioPharma Neutral Vaxxinity Neutral Does the MarketBeat Community favor SCPS or VAXX? Vaxxinity received 3 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 38.46% of users gave Vaxxinity an outperform vote. CompanyUnderperformOutperformScopus BioPharmaOutperform Votes2100.00% Underperform VotesNo VotesVaxxinityOutperform Votes538.46% Underperform Votes861.54% Is SCPS or VAXX more profitable? Company Net Margins Return on Equity Return on Assets Scopus BioPharmaN/A N/A N/A Vaxxinity N/A N/A N/A SummaryScopus BioPharma and Vaxxinity tied by winning 3 of the 6 factors compared between the two stocks. Get Scopus BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCPS vs. The Competition Export to ExcelMetricScopus BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13,000.00$6.36B$5.27B$8.46BDividend YieldN/A2.65%4.95%4.15%P/E RatioN/A8.8926.5819.69Price / SalesN/A269.77392.77118.72Price / CashN/A65.8538.2534.62Price / BookN/A6.346.684.52Net Income-$11.61M$143.46M$3.22B$248.10M7 Day PerformanceN/A4.81%4.14%4.49%1 Month PerformanceN/A10.65%10.56%13.85%1 Year PerformanceN/A-6.31%13.83%5.82% Scopus BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCPSScopus BioPharmaN/A$0.00flatN/A-85.7%$13,000.00N/A0.009VAXXVaxxinityN/A$0.00-99.6%N/A-81.5%$25,000.00N/A0.0090Gap UpEVLOEvelo BiosciencesN/A$0.00-40.0%N/A-99.3%$6,000.00N/A0.00120Options VolumeNews CoverageGNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst ForecastNews CoverageARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.8%$5,000.00$3.09M0.0030High Trading VolumeSTABStatera BiopharmaN/A$0.00flatN/A-85.7%$5,000.00N/A0.0020SMFLSmart for LifeN/A$0.00-40.0%N/A-99.4%$4,000.00$11.11M0.00110AMPEAmpio PharmaceuticalsN/A$0.00+237.5%N/A-98.6%$3,000.00N/A0.0020Gap UpCMRAComera Life SciencesN/AN/AN/AN/A$3,000.00$1.00M0.002EFTReFFECTOR TherapeuticsN/A$0.00flatN/A-100.0%$1,000.00$3.55M0.0010Gap Up Related Companies and Tools Related Companies Vaxxinity Competitors Evelo Biosciences Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors Smart for Life Competitors Ampio Pharmaceuticals Competitors Comera Life Sciences Competitors eFFECTOR Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCPS) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredCan This System Really Predict Stocks to the Day?Imagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict t...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredLenin was right all along… It’s not often you hear praise for a Bolshevik from a veteran investor… but Porter Stansberry says Lenin got o...Porter & Company | SponsoredPrepare now for May 31 eventMUST SEE: Elon Musk's latest project He's one of the most controversial men on the planet. But the Tesla fo...Stansberry Research | Sponsored“America is running out of power” - The Washington PostAccording to The Washington Post, AI is causing America to “run out of power”... It’s true — utility compan...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scopus BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scopus BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SCPS Stock Free SCPS Stock Alerts